CDEK
← All organizations

Inflamax

For profitWebsite ↗

Also known as: Inflamax Research | Inflamax Research Limited | Inflamax Research Ltd. | Inflamax Researc Incorporated

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2013

Last known activity

Nov 21, 2018

Acquired by Cliantha Research Limited on Apr 24, 2017

Timeline

2010s

  1. Jan 1, 2012

    Inflamax— Founded

  2. Apr 24, 2017

    Cliantha Research Limited— Acquired By

Drugs by trial phase (11 distinct, 14 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

  • NCT03758456Overall official - principal investigatorPhase 1Nov 21, 2018
  • NCT03158428CollaboratorN/AMay 8, 2017
  • NCT03153761CollaboratorN/AMay 8, 2017
  • NCT03087786Overall official - principal investigatorPhase 3Mar 1, 2017
  • NCT03087786CollaboratorPhase 3Mar 1, 2017
  • NCT02556801Overall official - principal investigatorPhase 2Sep 1, 2015
  • NCT02557633CollaboratorPhase 1Aug 1, 2015
  • NCT02578914Overall official - principal investigatorPhase 2Aug 1, 2015
  • NCT02481856Overall official - principal investigatorPhase 2Jun 1, 2015
  • NCT02481856CollaboratorPhase 2Jun 1, 2015
  • NCT02163122Overall official - principal investigatorEarly Phase 1Jan 1, 2015
  • NCT02271009CollaboratorPhase 2Oct 1, 2014
  • NCT02297490CollaboratorPhase 2Jan 1, 2014
  • NCT02061709Overall official - principal investigatorPhase 2Jan 1, 2014
  • NCT02727205Reponsible party - principal investigatorPhase 1Aug 1, 2013

Details

Founded
Mississauga, CA Jan 1, 2012
Last known activity
Nov 21, 2018